Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet

Haemonetics (HAE) closed the last trading session at $84.21, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 112.17 indicates a 33.2% upside potential.The average comprises six short-term price targets ranging from a low of $94 to a high of$ 125, with a standard deviation of $10.87. While the lowest estimate indicates an increase of 11.6% from the current price level, t ...